Categories

Pfizer Voluntary Nationwide Recall of Lots of ACCUPRIL® (Quinapril HCl) Due to N-Nitroso-Quinapril Content

Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient (consumer/user) level due to the presence of a nitrosamine, Nnitroso-quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pfizer-voluntary-nationwide-recall-lots-accuprilr-quinapril-hcl-due-n-nitroso-quinapril-content

 
Categories

👏 "Thanks to the tireless commitment of healthcare workers, scientists, policymakers, and citizens across our 🌎 Region, 14 countries have

👏 "Thanks to the tireless commitment of healthcare workers, scientists, policymakers, and citizens across our 🌎 Region, 14 countries have already reached the @WHO goal of fully vaccinating 70% of their populations ahead of the 🗓 June 30th target" @DirOPSPAHO #COVID19 https://t.co/kw7dE5SSms